Evoke Pharma Financial Overview
Evoke Pharma's market cap is currently $18.95M. The company's EPS TTM is $-0.45; its P/E ratio is -4.62; Evoke Pharma is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
